BridgeMD
Tests treatment safety and results for Unruptured Intracranial Aneurysm
Official title Efficacy and Safety of Transcutaneous Auricular Vagus Nerve Stimulation for Postoperative Headache Following Stent-Assisted Coiling of Unruptured Intracranial Aneurysms
ClinicalTrials.gov ID: NCT07479082
What this study is testing
- What it's testing
- The goal of this clinical trial is to evaluate the efficacy and safety of transcutaneous auricular vagus nerve stimulation (taVNS) in reducing postoperative headache among adults undergoing stent-assisted coiling for unruptured intracranial aneurysms (UIAs). The study will include male and female participants aged 18 to 80 years who are scheduled for endovascular treatment of UIAs with stent-assisted coiling or flow diverter devices.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age 18-80 years
- Diagnosed with unruptured intracranial aneurysm confirmed by imaging
- Planned to undergo stent-assisted coiling or flow diverter embolization
- Signed informed consent
You likely can't join if
- History of SAH, ICH, brain tumor, major trauma, substance abuse, syncope, or seizures
- Recurrent/traumatic/infectious/myxomatous aneurysms
- Primary headache disorders (e.g., migraine, cluster headache, trigeminal neuralgia) not attributed to UIA
- Previous vagotomy, migraine surgery, or implanted neurostimulators
- Other concurrent electronic/implantable devices (e.g., pacemakers, neurostimulators)
- Clinically significant hypotension, congenital heart disease, severe arrhythmia, unstable angina, or recent MI
See the full eligibility criteria
- Age 18-80 years
- Diagnosed with unruptured intracranial aneurysm confirmed by imaging
- Planned to undergo stent-assisted coiling or flow diverter embolization
- Signed informed consent
- History of SAH, ICH, brain tumor, major trauma, substance abuse, syncope, or seizures
- Recurrent/traumatic/infectious/myxomatous aneurysms
- Primary headache disorders (e.g., migraine, cluster headache, trigeminal neuralgia) not attributed to UIA
- Previous vagotomy, migraine surgery, or implanted neurostimulators
- Other concurrent electronic/implantable devices (e.g., pacemakers, neurostimulators)
- Clinically significant hypotension, congenital heart disease, severe arrhythmia, unstable angina, or recent MI
- Inability to follow up due to severe psychiatric disorder or refusal
- Skin lesions at taVNS placement site
- Pregnant or lactating
- Participation in other trials
The study team makes the final eligibility decision.
Where it's taking place
- Beijing, Beijing Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Beijing, Beijing Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.